Pricing Log in Create free account
Saturday 17 October 2026 Export BIIB’s income statement to Excel — free account

Biogen Inc.

BIIB Healthcare Drug Manufacturers General

Biogen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.9 billion, up 2.22% from fiscal 2024. In the quarter to June 2026, revenue grew 3.42%, EPS fell 84.8%, free cash flow grew 103.3% and total debt rose 16.0%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.

232.65 2.70 −1.15%
Market cap
$34.8B
P/E
41.0×
Fwd P/E
31.5×
Dividend yield
—
F-score
4/9
Altman Z
3.13
Beneish M
−2.67
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Biogen Inc. (BIIB) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Biogen Inc. (BIIB) trades at a P/E ratio of 41.0×. Over the past ten years it has ranged from 7.7× (July 2020) to 41.4× (October 2026); the current reading is higher than 100% of that period. That is above the Drug Manufacturers General industry median of 24.5× and above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 19.9× 46.24%
FY2024 13.6× (59.12%)
FY2023 33.3× 156.68%
FY2022 13.0× (43.53%)
FY2021 23.0× 130.16%
FY2020 10.0× 6.16%
FY2019 9.4× (32.30%)
FY2018 13.9× (50.36%)
FY2017 28.0× 62.76%
FY2016 17.2× (13.66%)

Quarterly newest first

Period P/E ratio Change
Jun 2026 38.0× 94.00%
Mar 2026 19.6× (1.62%)
Dec 2025 19.9× 56.37%
Sep 2025 12.7× 6.36%
42 more quarters

Against its own ten years

Low 7.7× High 41.4×
Ten-year median 17.2×
Current reading's percentile 100

P/E ratio against peers

Company P/E ratio
GILD Gilead Sciences, Inc. compare n/m
NVO Novo Nordisk A/S compare 9.5×
BMY Bristol Myers Squibb Company compare 13.2×
GSK GSK PLC Sponsored ADR compare 15.4×
SNY Sanofi compare 21.3×
AZN AstraZeneca PLC compare 24.5×
AMGN Amgen Inc. compare 26.7×
PFE Pfizer Inc. compare 38.9×
BIIB Biogen Inc. 41.0×
Drug Manufacturers General industry median 24.5×
Healthcare sector median 23.0×
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on BIIB